Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
Cardiovascular and Endothelial Benefits GLP-1 RAs have demonstrated robust cardiovascular protection in multiple large-scale trials, including LEADER, REWIND, and SUSTAIN-6, showing reduced rates of major adverse cardiac events independent of weight loss
Currently, the Food and Drug Administration (FDA) has approved seven GLP-1 prescription medications: When used in addition to a reduced calorie diet and increased physical activity , these medications are FDA approved for one or more of the following: Improving blood sugar levels in adults with T2D
New Engl J Med
doi: 10.1056/NEJMc1712572 35 Aristizbal-ColoradoDOcampo-PosadaMRivera-MartnezWACorredor-RengifoDRico-FontalvoJGmez-MesaJEet al
Type 2 Diabetes Prevalence and Etiology T2D is a common metabolic disorder characterized by major dysregulations in glucose homeostasis
US$ 23.59
US$ 27.24
US$ 24.91
US$ 28.73
US$ 27.30
US$ 23.95
